Full-Time

Therapeutic Sales Specialist

Cincinnati

Posted on 8/21/2024

BridgeBio

BridgeBio

501-1,000 employees

Develops medicines for genetic diseases

Biotechnology

Compensation Overview

$140k - $185kAnnually

+ Performance Bonus + Equity + Health Benefits

Senior, Expert

Remote in USA

Category
Field Sales
Sales & Account Management
Required Skills
Sales
Communications
Data Analysis
Requirements
  • 8+ years of successful experience in the pharmaceutical industry and 5+ years in Rare Disease/Cardiology/Specialty/ATTR
  • BS/BA Required, MBA Preferred but not required
  • Product/indication launch experience: Track record of successfully launching new products and/or new indications into highly competitive markets
  • Strong leadership, planning and organization, analytics, business acumen, decision making and problem-solving skills
  • Ability to prioritize and execute on plan
  • Proven leadership skills with a history of holding oneself to a high level of accountability
  • Ability to influence without authority, internally as well as externally
  • Excellent written and oral communication skills
  • Excellent skills in using remote technology to engage with customers
  • Adherence to BridgeBio’s high ethical standards
  • Significant travel is required
Responsibilities
  • Meeting and/or exceeding sales goals in an assigned territory by developing, implementing, and executing an integrated territory business plan encompassing key customer target
  • Will demonstrate subject matter expertise concerning scientific and clinical information for Acoramidis
  • Will take a customer centric-approach and engage customers in clinically relevant discussion utilizing approved materials
  • Will effectively analyze sales data to identify opportunities for business growth or areas of concern in their territory
  • Be responsible for territory business planning and execution of key company initiatives
  • Will adhere to company guidelines and demonstrate honesty, integrity, trust, respect, and accountability and perform all responsibilities in accordance with company policies and procedures and applicable state and federal rules and regulations
  • Appropriately or compliantly? partners with Medical Science Liaisons, Field Reimbursement, Patient Access, HUB and other key cross-functional team members to develop strategies to ensure a high level of customer satisfaction
  • Navigates the hospital formulary process and develops and implements strategies to ensure successful product positioning and availability
  • Anticipates potential business challenges, adjusts priorities as needed, demonstrates flexibility, and develops solutions to address challenges
  • Maintains an exceptional level of proficiency in selling skills, clinical, market and product knowledge and the business environment of the territory
  • Collaborates with peers and company personnel to ensure corporate objectives and initiatives are achieved
  • Effectively plans and organizes schedule to ensure maximum efficiency and use of time to accomplish goals and objectives
  • Acts as an ambassador on behalf of the company. Presents a professional image and represents the company, products and people with integrity and respect
  • Completes tasks and projects assigned by Sales Leadership
  • Ensures that all activities are following applicable regulations, compliance and Pharma guidelines

BridgeBio Pharma develops medicines specifically for genetic diseases, focusing on conditions with well-understood genetic causes. The company uses a decentralized subsidiary model, allowing each subsidiary to concentrate on specific therapies while sharing central resources. This structure enhances efficiency and enables the advancement of multiple drug programs at once. BridgeBio utilizes advancements in genome sequencing and molecular biology to identify and develop effective treatments. Their goal is to create significant therapeutic improvements by targeting diseases at their genetic source. With over 15 drug programs aimed at 20 different genetic diseases, BridgeBio aims to bring treatments to market more quickly than traditional biopharma processes. The company promotes a culture of independent thinking and transparency, which supports rapid, data-driven decision-making.

Company Stage

IPO

Total Funding

$704.4M

Headquarters

Palo Alto, California

Founded

2014

Growth & Insights
Headcount

6 month growth

3%

1 year growth

2%

2 year growth

-2%
Simplify Jobs

Simplify's Take

What believers are saying

  • Significant investment by Norges Bank shows strong investor confidence in BridgeBio.
  • Partnership with PANTHERx Rare enhances market penetration for rare disease therapies.
  • KRAS inhibitors development positions BridgeBio in a promising cancer treatment market.

What critics are saying

  • Alnylam's RNAi therapy poses competitive pressure on BridgeBio's Attruby.
  • Decentralized model may challenge cohesive strategic direction across programs.
  • Increased competition in KRAS inhibitors could impact BridgeBio's market share.

What makes BridgeBio unique

  • BridgeBio employs a decentralized subsidiary model for efficient drug development.
  • Focus on genetic diseases allows targeting conditions with well-understood genetic causes.
  • Partnerships with specialty pharmacies enhance patient access to rare disease therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Performance Bonus

Company Equity

Unlimited Paid Time Off

INACTIVE